Clinical Trial Update: Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating albumin-bound paclitaxel plus camrelizumab for advanced soft tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Albumin-bound paclitaxel (nab-paclitaxel)
• Camrelizumab (camrelizumab)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: UNKNOWN